Katharine Owen
Associate Professor of Diabetes
- NIHR Clinician Scientist
- Honorary Consultant Physician
Genetics of Type 2 Diabetes & Monogenic Diabetes
Diabetes arising in young adults has a wide range of underlying aetiologies. This includes genetic causes of beta-cell dysfunction (Maturity-onset diabetes of the young, MODY). We are investigating the characteristics of different subtypes of MODY and how to identify them from those with commoner causes of diabetes. Our research programme aims to implement systematic diagnostics for aetiology of diabetes into routine clinical care. At the moment we are investigating whether there are specific non-genetic biomarkers for MODY subtypes and have recently discovered that low levels of highly-sensitive C-reactive protein are a marker for HNF1A mutations.
Recent publications
-
Effects of guidance changes for gestational diabetes (GDM) in a UK hospital setting during the covid-19 pandemic: A before and after comparison of management and outcome
Conference paper
HIRST J. et al, (2021), Diabetic Medicine
-
Diabetes in pregnancy: time to focus on women with type 2 diabetes
Journal article
HIRST J. et al, (2021), Lancet Diabetes and Endocrinology
-
Interlaboratory evaluation of plasma N-glycan antennary fucosylation as a clinical biomarker for HNF1A-MODY using liquid chromatography methods.
Journal article
Demus D. et al, (2021), Glycoconj J
-
Logistic regression has similar performance to optimised machine learning algorithms in a clinical setting: application to the discrimination between type 1 and type 2 diabetes in young adults
Journal article
Lynam AL. et al, (2020), Diagnostic and Prognostic Research, 4
-
Maturity onset diabetes of the young and fibrin-related thrombosis risk.
Journal article
Sagar RC. et al, (2020), Diab Vasc Dis Res, 17